NCT00412191View on ClinicalTrials.gov

Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR

PHASE1CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

February 6, 2007

Primary Completion Date

April 27, 2007

Study Completion Date

April 27, 2007

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine

In treatment regimen A lamotrigine XR tablets will be available 100 and 200mg tablets, for regimen B and C of lamotrigine tablets 300 mg will be available.

Trial Locations (1)

14050

GSK Investigational Site, Berlin